Drug intelligence / Profile preview

Diben

Development stage: Unknown
Lead developer: Fresenius Kabi
Administration: Oral

Overview

Diben is a specialized enteral nutrition product (food for special medical purposes) developed by Fresenius Kabi for the dietary management of patients with or at risk of malnutrition and impaired glucose metabolism, such as diabetes mellitus or stress-induced hyperglycemia. It is a nutritionally complete, high-caloric (1.5 kcal/ml), and high-protein formula enriched with fiber and monounsaturated fatty acids. The product is designed with a modified carbohydrate profile to provide a low glycemic index, aiding in improved glycemic control. Diben is available in various formats, including oral nutritional supplements (drinks), tube feeds, and powder, and is gluten- and lactose-free.

Brand names: Diben
Other names: Diben DrinkDiben Tube FeedDiben Powder

Beyond the preview

Go deeper on Diben.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diben.

Explore the full profile